Name | Title | Contact Details |
---|---|---|
Kevin Fallon |
Vice President of Technology | Profile |
Naser Ahmad |
Chief Technology Officer | Profile |
Jeffrey Walsh |
Chief Information Officer | Profile |
Joseph Wagner |
Chief Technology Officer | Profile |
Ismet Turan |
Chief Technology Officer | Profile |
Seashore (CSE:SOM) was formed to become a producer of medical marijuana under the MMPR. Our team and board of advisors have a diverse range of experience and multi-industry expertise, and hold the knowledge and skill necessary for success in this industry.
Spyryx Biosciences was formed in 2013 by our scientific founder, Dr. Robert Tarran, based on his discovery of a previously unknown mechanism that the lung uses to regulate fluid on its surface. This mechanism is dysfunctional in the lungs of CF patients due to genetic mutations and is believed to be the root cause of the progressive dehydration that leads to the unfortunate cycle of mucus accumulation, bacterial colonization, immune response and tissue scarring, loss of lung function, and often early death.